Dugos, Baby Girl .
HRN: 22-87-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2023
AMPICILLIN 500MG (VIAL)
04/15/2023
04/21/2023
IVT
135mg
Q12hrs
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes